LongBSXJun 2026
Boston Scientific Corporation
Boston Scientific shares weakened after quarterly results and CHAMPION-AF data failed to provide the positive catalyst investors had hoped for. U.S. Electrophysiology and…
BSX
1 published idea on Boston Scientific Corporation across 1 fund — 1 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Boston Scientific Corporation: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Boston Scientific shares weakened after quarterly results and CHAMPION-AF data failed to provide the positive catalyst investors had hoped for. U.S. Electrophysiology and…